Cargando…

Herbal medicine for the management of COVID-19 during the medical observation period: A review of guidelines

BACKGROUND: Medical observation period is a period of 14 days after any exposure to coronavirus disease 2019 (COVID-19) occurred. This review aimed to summarize and analyze the herbs and herbal formulae recommended by available guidelines. METHODS: A total of 14 sources were searched for potential g...

Descripción completa

Detalles Bibliográficos
Autores principales: Ang, Lin, Lee, Hye Won, Kim, Anna, Lee, Myeong Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328533/
https://www.ncbi.nlm.nih.gov/pubmed/32691000
http://dx.doi.org/10.1016/j.imr.2020.100465
_version_ 1783552740937433088
author Ang, Lin
Lee, Hye Won
Kim, Anna
Lee, Myeong Soo
author_facet Ang, Lin
Lee, Hye Won
Kim, Anna
Lee, Myeong Soo
author_sort Ang, Lin
collection PubMed
description BACKGROUND: Medical observation period is a period of 14 days after any exposure to coronavirus disease 2019 (COVID-19) occurred. This review aimed to summarize and analyze the herbs and herbal formulae recommended by available guidelines. METHODS: A total of 14 sources were searched for potential guidelines that provide herbal medicine treatment for the medical observation period of COVID-19. We summarized and analyzed the recommended herbal formulae and performed a network analysis to identify the relationship between herbs. RESULTS: We found 9 guidelines that provide herbal formula for medical observation based on clinical manifestation. There are 12 herbal formulae with a total of 53 herbs recommended by the guidelines. The result of our network analysis showed that the herb Citri Reticulatae Pericarpium (Chen Pi) strongly paired with the herb Glycyrrhizae Radix et Rhizoma (Gan Cao). CONCLUSION: This review briefly summarized the usage of herbal medicine for the medical observation period of COVID-19 and may serve as a reference for future studies. More research is needed in the future to provide evidence on the usage of herbal medicine in various phases of COVID-10.
format Online
Article
Text
id pubmed-7328533
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-73285332020-07-01 Herbal medicine for the management of COVID-19 during the medical observation period: A review of guidelines Ang, Lin Lee, Hye Won Kim, Anna Lee, Myeong Soo Integr Med Res Review Article BACKGROUND: Medical observation period is a period of 14 days after any exposure to coronavirus disease 2019 (COVID-19) occurred. This review aimed to summarize and analyze the herbs and herbal formulae recommended by available guidelines. METHODS: A total of 14 sources were searched for potential guidelines that provide herbal medicine treatment for the medical observation period of COVID-19. We summarized and analyzed the recommended herbal formulae and performed a network analysis to identify the relationship between herbs. RESULTS: We found 9 guidelines that provide herbal formula for medical observation based on clinical manifestation. There are 12 herbal formulae with a total of 53 herbs recommended by the guidelines. The result of our network analysis showed that the herb Citri Reticulatae Pericarpium (Chen Pi) strongly paired with the herb Glycyrrhizae Radix et Rhizoma (Gan Cao). CONCLUSION: This review briefly summarized the usage of herbal medicine for the medical observation period of COVID-19 and may serve as a reference for future studies. More research is needed in the future to provide evidence on the usage of herbal medicine in various phases of COVID-10. Elsevier 2020-09 2020-07-01 /pmc/articles/PMC7328533/ /pubmed/32691000 http://dx.doi.org/10.1016/j.imr.2020.100465 Text en © 2020 Korea Institute of Oriental Medicine. Publishing services by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review Article
Ang, Lin
Lee, Hye Won
Kim, Anna
Lee, Myeong Soo
Herbal medicine for the management of COVID-19 during the medical observation period: A review of guidelines
title Herbal medicine for the management of COVID-19 during the medical observation period: A review of guidelines
title_full Herbal medicine for the management of COVID-19 during the medical observation period: A review of guidelines
title_fullStr Herbal medicine for the management of COVID-19 during the medical observation period: A review of guidelines
title_full_unstemmed Herbal medicine for the management of COVID-19 during the medical observation period: A review of guidelines
title_short Herbal medicine for the management of COVID-19 during the medical observation period: A review of guidelines
title_sort herbal medicine for the management of covid-19 during the medical observation period: a review of guidelines
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328533/
https://www.ncbi.nlm.nih.gov/pubmed/32691000
http://dx.doi.org/10.1016/j.imr.2020.100465
work_keys_str_mv AT anglin herbalmedicineforthemanagementofcovid19duringthemedicalobservationperiodareviewofguidelines
AT leehyewon herbalmedicineforthemanagementofcovid19duringthemedicalobservationperiodareviewofguidelines
AT kimanna herbalmedicineforthemanagementofcovid19duringthemedicalobservationperiodareviewofguidelines
AT leemyeongsoo herbalmedicineforthemanagementofcovid19duringthemedicalobservationperiodareviewofguidelines